Abstract
Sydney, Australia, is currently experiencing an outbreak of the Delta variant of Covid-19. The Delta variant is much more transmissible than the original ‘wild’ variant of SARS-CoV-2, which was responsible for Australia’s first wave of infections, and for the second wave largely confined to Melbourne in mid-2020. Our purpose here is to compare growth rates for the current Sydney outbreak with those of the earlier outbreaks, using doubling times as the principal indicator. By such means, it appears that non-pharmaceutical interventions are achieving similar, if not stronger effects in containing Sydney’s Delta-variant outbreak.
| Original language | English |
|---|---|
| Number of pages | 3 |
| Journal | Global Biosecurity |
| Volume | 3 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 6 Jul 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- coronavirus
- Covid-19
- Delta variant
- epidemic
- infectious disease
- pandemic
- SARS-CoV-2
Fingerprint
Dive into the research topics of 'Observations on the Current Outbreak of the SARS-CoV-2 Delta Variant in Sydney'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver